Executive Change

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  July 23, 2020   NATURE’S SUNSHINE PRODUCTS, INC. (Exact name of registrant specified in its charter)   Utah   001-34483   87-0327982 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   2901 West Bluegrass Blvd., Suite 100, Lehi, Utah   84043 (Address of principal executive offices)   (Zip Code)   Registrant’s telephone, including area code:   (801) 341-7900   N/A (Former name and former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):   o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value NATR Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 23, 2020, Nature's Sunshine Products, Inc. (the "Company") appointed Ms. Heidi Wissmiller to its Board of Directors. Ms. Wissmiller was appointed to serve as a director until the next shareholders’ meeting at which directors are elected. Ms. Wissmiller will initially serve on the Audit and Risk Management Committees. Ms. Wissmiller, 55, served in multiple C-suite positions for Rodan + Fields from 2014 to April 2019, including chief growth officer and chief operating officer of global field sales and operations. Prior to Rodan + Fields, Ms. Wissmiller was the CEO for Micro Analytical Systems. She previously served in various senior leadership roles with globally recognized companies, including PepsiCo, E & J Gallo Winery and Nabisco. The Board of Directors determined that Ms. Wissmiller is an independent director under the current standards for independence established by NASDAQ. SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.     NATURE’S SUNSHINE PRODUCTS, INC.       Dated: July 29, 2020 By: /s/ Nathan G. Brower     Nathan G. Brower, Executive Vice President, General Counsel and Secretary